This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Cramer's 'Mad Money' Recap: Market Craves Certainty (Final)

Anticipated Break-Up

For the next installment of his "Diamonds of the Dow" series, Cramer recommended Kraft Foods (KFT), the household name that rose 17.6% last year and sports a 3.1% dividend yield.

Cramer said while Kraft delivered strong results last quarter, the real value lies in its plans to split itself into two companies by the end of this year. As it's currently configured, Kraft is simply too big and diverse for investors to wrap their arms around, said Cramer.

The stock grows too slowly for the growth investors to get excited and the company isn't in the wheelhouse of the value investors either, leaving it in a stock no-man's-land, he explained.

But that all changed last year when Kraft announced that it's splitting into a fast-growing global snack foods business and a slower-growing domestic grocery business. On the surface, investors would think that food is food, but that's not the case, said Cramer.

He explained that grocery items and snack foods have totally different distribution models, different margins and most importantly, different growth prospects. The real value, he said, will be unlocked after these two entities are separated.

Cramer said he expects shares of Kraft to be propelled higher throughout this year as anticipation of the break-up builds. Until then, the company will continue to pay its juicy 3.1% dividend, making the deal even sweeter.

Playoff Battle

Continuing with his "Stock Super Bowl" series, it was play-off night for the top two performing Nasdaq stocks, Ross Stores (ROST - Get Report) and Alexion Pharmaceuticals (ALXN - Get Report), to see which company will square off against Cramer's Dow Jones Industrial Average winner, Cabot Oil & Gas (COG), from last night's show.

Cramer said that on the surface it may seem difficult to compare an orphan drug maker with a discount retailer, but some metrics span every sector. His first match-up was the companies' PEG ratios, which compare their multiples vs. their growth rates. Ross Stores may seem like the cheaper play at just 14.9 times earnings, but when factoring in growth, it's a draw, said Cramer. Alexion's PEG ratio is 1.2 while Ross Stores had a PEG ratio of 1.4.

Cramer's next category was takeover potential. Here he said Alexion has the edge, as there simply aren't that many acquirers for Ross. In biotech, however, the possibilities are endless, he said.

Next, Cramer looked at surprise catalysts for these two contenders. He said that Ross Stores is able to take market share and has some exciting new store concepts, but that's nothing that investors aren't already expecting. Alexion on the other hand, has not only new drugs in its pipeline, but is also developing new indications for many of its existing drugs as well. Advantage Alexion, said Cramer.

Finally, on the defensive side, Cramer looked at dividends, where Ross Stores came out the clear winner with its 1.8% yield. Alexion is a growth stock, said Cramer, and all of its profits will go right back into research and development.

Tallying up the results, Cramer said that Alexion came out ahead by a hair, with a score of eight points to Ross' seven points. He said that Alexion will take on Cabot Oil & Gas in the stock Super Bowl on Friday's show.
2 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ACC $44.75 0.00%
ALXN $139.28 0.00%
EOG $82.62 0.00%
HAL $41.31 0.00%
INTC $30.28 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs